Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-04
2005-01-04
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S247000, C544S242000, C544S330000
Reexamination Certificate
active
06838453
ABSTRACT:
The invention concerns vitronectin receptor antagonist compounds of formula (3): R1—Y—A—B—D—E—F—G wherein R1, Y, A, B, D, E, F, and G are as defined in the description, their physiologically acceptable salts and their prodrugs, methods for preparing compounds of formula (I), their use, in particular as medicine and pharmaceutical compositions containing them.
REFERENCES:
patent: 535521 (1993-04-01), None
patent: 0820988 (1998-01-01), None
patent: 0820991 (1998-01-01), None
patent: 9937621 (1999-07-01), None
patent: 9945927 (1999-09-01), None
patent: 0018759 (2000-04-01), None
Fernandes et al, PubMed Abstract12082286, also cited as Biorheology, 39/1-2,237-46 (2002).*
McFarlane et al, PubMed Abstract 15034190, also cited as Endocrine,23/1,1-10(2004).*
Koobi et al, PubMed Abstract 15058982, also cited as Nephron. Exp. Nephrol. 96/3,91-8(2004).*
Cecil textbook of medicine, 20thEdition, vol. 1, 1004-1010(1996).*
Uckun et al, Current Cancer Drug Targets,1,59-71(2001).*
Chemical Abstract DN 119:249940, also cited as EP535521.*
Chemical Abstract DN 131:214194.*
Gobbo et al, PubMed Abstract 15062975, also cited as Neuroscience, 125/2,317-27(2004).*
Lein et al, PublMed Abstract 14716014, also cited as Science, 303/5655,229-32(2004).
Demassey Jacques
Gourvest Jean-Francois
LeFrancois Jean-Michel
Ruxer Jean-Marie
Weston John Bernard
Aventis Pharma S.A.
Muserlian Lucas and Mercanti
Patel Sudhaker B.
Raymond Richard L.
LandOfFree
Antagonist derivatives of the vitronectin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antagonist derivatives of the vitronectin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antagonist derivatives of the vitronectin receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437609